NCT00553345Unknown3 期
Bladder Cancer Prognosis Programme (Incorporating SELENIB Trial) [TREATMENT]
适应症
相关药物
试验速览
- 阶段
- 3 期
- 入组人数
- 515
- 试验地点
- 2
- 主要终点
- Recurrence-free interval
研究概览
简要总结
RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming. The use of selenium and vitamin E may stop cancer from growing or coming back.
PURPOSE: This randomized phase III trial is studying giving selenium together with vitamin E to see how well it works compared with a placebo in preventing cancer progression and recurrence in patients with early-stage bladder cancer.
详细描述
OBJECTIVES:
- To investigate whether selenium and/or vitamin E (α-tocopherol) supplementation reduces the risk of recurrence and progression.
OUTLINE: This is a multicenter study. Patients are stratified by recurrence risk group (high vs intermediate) and treatment center and randomized to 1 of 4 treatment arms.
- Arm I: Patients receive oral selenium tablet and oral vitamin E capsule once daily.
- Arm II: Patients receive oral selenium tablet and oral placebo capsule once daily.
- Arm III: Patients receive oral placebo tablet and oral vitamin E capsule once daily.
- Arm IV: Patients receive oral placebo tablet and oral placebo capsule once daily.
In all arms, treatment continues for up to 5 years in the absence of disease progression or unacceptable toxicity.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 主要目的
- Prevention
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Recurrence-free interval
次要结局
- Incidence of cardiovascular events
- Incidence of transitional cell carcinoma outside the bladder
- Incidence of all other malignancies clinically diagnosed
- Overall survival time
- Quality of life as assessed at each follow-up visit by the quality of life instruments EORTC QLQ-C30, QLQ-BLS24 and QLQ-BLM30
- Progression-free interval
研究者
研究点 (2)
Loading locations...
相似试验
已完成
3 期
S9917, Selenium in Preventing Cancer in Patients With Neoplasia of the ProstatePrecancerous/Nonmalignant ConditionProstate CancerNCT00030901SWOG Cancer Research Network619
已完成
3 期
Selenium in Preventing Cancer Recurrence in Patients With Bladder CancerBladder CancerNCT00729287KU Leuven276
已完成
不适用
Selenium in the Prevention of CancerUnspecified Adult Solid Tumor, Protocol SpecificNCT00022165University of Surrey501
已完成
3 期
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung CancerLung CancerNCT00008385ECOG-ACRIN Cancer Research Group1,772
已完成
3 期
S0000 Selenium and Vitamin E in Preventing Prostate CancerProstate CancerNCT00006392SWOG Cancer Research Network35,533